Gardenia jasminoides Ellis is a well-known herbal medicine. In this study, the effect of G. jasminoides Ellis
polysaccharide (GPS) on liver injury in an
alpha-naphthylisothiocyanate (ANIT)-induced cholestatic mouse model and the associated molecular mechanisms were investigated. GPS administration dose-dependently ameliorated impaired hepatic function, including a 2-7-fold decrease in
aminotransferase levels, ameliorating tissue damage, upregulating the expression of farnesoid X receptor (FXR) and
pregnane X receptor (PXR) and their downstream efflux transporters, and decreasing the levels of 12
bile acids (BAs), in cholestatic mice. Furthermore, GPS ameliorated gut microbiota
dysbiosis, improved intestinal barrier function, and reduced serum and hepatic
lipopolysaccharide levels 1.5-fold. GPS also inhibited the
Toll-like receptor 4 (TLR4)/
nuclear factor kappa-B (NF-κB) signaling, decreased the expression of inflammatory factor genes, and ameliorated hepatic
inflammation. Notably,
fecal microbiota transplantation from GPS-fed mice also increased the hepatic expression of FXR, PXR, and efflux transporters; decreased the levels of 12 BAs; restored intestinal barrier function; and decreased hepatic
inflammation mediated by the TLR4/NF-κB pathway. In conclusion, GPS has a protective effect against cholestatic liver injury through modulation of gut microbiota and inhibition of the TLR4/NF-κB pathway. Regulating gut microbiota using herbal medicine
polysaccharides may hold unique therapeutic promise for cholestatic
liver diseases.